EMA Regulatory Science to 2 0 2 5 Session 1 : Responding to the - PowerPoint PPT Presentation

Apr 22, 2023 •500 likes •625 views

EMA Regulatory Science to 2 0 2 5 Session 1 : Responding to the needs of the 2 1 st century patient. Addressing challenges and opportunities across the European Regulatory Fram ew ork Olga Solom on Horizon Europe is the Commission proposal

EMA – Regulatory Science to 2 0 2 5 Session 1 : Responding to the needs of the 2 1 st century patient. Addressing challenges and opportunities across the European Regulatory Fram ew ork Olga Solom on
Horizon Europe is the Commission proposal for a research and innovation funding programme for seven years (2021-2027) to strengthen the EU's scientific and technological bases to boost Europe's innovation capacity, com petitiveness and jobs to deliver on citizens' priorities and sustain our socio-econom ic m odel and values
Real w orld data in health care • Multiple sources of data: • Clinical databases (prescriptions, EHR, registries) • Clinical databases (prescriptions, • Clinical trials EHR, registries) • Imaging data • Clinical trials • 'mc data' • Imaging data • Published literature • 'Omic data' • Published literature • Regulatory pharmacovigilance data • Regulatory pharmacovigilance data • Social media/ Health data • Social media/ mHealth data
Com m ission Com m unication of 2 5 April 3 Priority areas on digitising Health and Care
EU Legislation on Clinical Trials Regulation EU No 536/ 2014  Simplified and harmonized administrative provisions  Closer coordination between MS for international CTs  Increased transparency
Evaluation of the paediatric and of the orphan regulations Paediatric study/report on Reg. 1901/2006 : EVALUATION Pulic health impact Economic impact Incentives study Impact on innovation, availability accessibility Gap Analysis study for evaluation of orphans
Evaluation • Identification of the problems; • Strengths and weaknesses of paediatric and orphan legislations alone and combined; • How incentives have been used; • Finalisation by the end of 2019; • Base for the next Commission to decide future policy choices.
From Directives to Regulations Directive 90/ 385/ EEC on active implantable medical devices Directive 93/ 42/ EEC on medical devices → Regulation on MD ( 2 0 1 7 / 7 4 5 ) Directive 98/ 79/ EC on in vitro diagnostic medical devices → Regulation on I VD ( 2 0 1 7 / 7 4 6 ) Necessity to harmonise the legislation in Member States and to adapt to health scandals: PIP implants; metal on metal hip implants…
Health Technology Assessm ent ( HTA) Proposal for a Regulation 31 January 2018
I m plem entation and Looking to the future

Recommend

Regulatory pathways to new medicines EU 28: science, medicines, health a regulatory system

Regulatory pathways to new medicines EU 28: science, medicines, health a regulatory system fit for the future 6 7 May 2013, Dubrovnik, Croatia Presented by: Tony Humphreys Head of Regulatory, Procedural and Scientific Committee

661 views • 26 slides

EMA Regulatory Science Strategy Challenges and Opportunities across the European Regulatory

EMA Regulatory Science Strategy Challenges and Opportunities across the European Regulatory Framework London, 6 December 2018 Alexander Bttner, on behalf of AnimalhealthEurope PAGE 2 Agenda Environment Challenges

574 views • 9 slides

EMA recommendations from the Regulatory Science Strategy to 2025 Implications for patients and

EMA recommendations from the Regulatory Science Strategy to 2025 Implications for patients and healthcare professionals PCWP/HCPWP joint meeting Presented by Tony Humphreys on 3 March 2020 Head of Regulatory Science and Innovation Task Force

255 views • 21 slides

Public-Private Partnership collaborating on Regulatory Science to make patient access to new

Public-Private Partnership collaborating on Regulatory Science to make patient access to new medical device technologies faster, safer and more cost-effective Dawn Bardot, PhD Senior Program Manager 1 What is Regulatory Science? The science

972 views • 19 slides

OFFICE OF REGULATORY AFFAIRS OFFICE OF REGULATORY SCIENCE Updates and Areas of Collaboration with

OFFICE OF REGULATORY AFFAIRS OFFICE OF REGULATORY SCIENCE Updates and Areas of Collaboration with NCTR Sean W. Linder, Ph.D. 1 www.fda.gov ORA Roles & Responsibilities Inspections of firms and plants producing FDA-regulated products

415 views • 12 slides

Applying Regulatory Science to Neonates: Launch of the International Neonatal Consortium The

Applying Regulatory Science to Neonates: Launch of the International Neonatal Consortium The ABCs of Regulatory Science Susan McCune, M.D. Session 1 May 18, 2015 Deputy Director Office of Translational Sciences CDER/FDA 1 Disclaimer

485 views • 34 slides

AN ITALIAN EXPERIENCE ON REGULATORY SCIENCE Walter Marrocco EFPC F.I.M.M.G. September 26 th

EMA HCPWP Regulatory sciences in fellowships and young researchers Share practices and experiences AN ITALIAN EXPERIENCE ON REGULATORY SCIENCE Walter Marrocco EFPC F.I.M.M.G. September 26 th 2018 Patent application 3 Preclinic Phase

437 views • 8 slides

Predicting Regulatory Elements Predicting Regulatory Elements in P. falciparum in P. falciparum

Predicting Regulatory Elements Predicting Regulatory Elements in P. falciparum in P. falciparum Chengyong Yang Erliang Zeng Giri Narasimhan BioInformatics Research Group (BioRG) School of Computer Science Florida International University,

525 views • 31 slides

Croatia Decision Making phasing-in EU 28: science, medicines, health a regulatory system

Croatia Decision Making phasing-in EU 28: science, medicines, health a regulatory system fit for the future 6 7 May 2013, Dubrovnik, Croatia Presented by: Tony Humphreys Head of Regulatory, Procedural and Scientific Committee

556 views • 6 slides

developments in regulatory science Claudia Heppner Senior science coordinator Background: SPIDO

76 th Advisory Forum meeting Virtual meeting, 1-2 July 2020 Preparedness for verification studies: integrating latest scientific developments in regulatory science Claudia Heppner Senior science coordinator Background: SPIDO and other

473 views • 8 slides

FDA CENTER FOR TOBACCO PRODUCTS AND & ITS TOBACCO REGULATORY SCIENCE PROGRAM Presented by

FDA CENTER FOR TOBACCO PRODUCTS AND & ITS TOBACCO REGULATORY SCIENCE PROGRAM Presented by Dana M. van Bemmel, PhD, MPH Assistant Deputy Director for Research Office of Science Disclaimer: This is not a formal dissemination of information

401 views • 17 slides

Translating regulatory science into better processes Eight Stakeholders forum on the

Translating regulatory science into better processes Eight Stakeholders forum on the implementation of the Pharmacovigilance legislation: Building on two years of operation Presented by: Xavier Kurz Head of Monitoring & Incident

145 views • 13 slides

International Regulatory Cooperation The regulatory perspective Nick Malyshev, Head, Regulatory

International Regulatory Cooperation The regulatory perspective Nick Malyshev, Head, Regulatory Policy Division OECD Public Governance and Territorial Development IRC: a long standing concern of regulators OECD (1994), Regulatory Co-operation

362 views • 7 slides

Science how can the scientific information needs of both HTAs and regulatory be accommodated

Science how can the scientific information needs of both HTAs and regulatory be accommodated in a common development track? Workshop on EMA HTA Parallel Scientific Advice 26 November 2013 Britta Paschen, VP, R&D / Health Services

466 views • 11 slides

Regulatory Regulatory Infrastructure Infrastructure Two National Regulatory Authorities in the

8/25/2006 INTERNAL REGULATORY CONTROL OF INTERNAL REGULATORY CONTROL OF PNRI FACILITIES AND LABORATORIES PNRI FACILITIES AND LABORATORIES Philippine Nuclear Research Institute Philippine Nuclear Research Institute Department of Science and

414 views • 8 slides

US US FD FDA Experience Experience in in the the Re Regulatory Applic Applicatio ion of of (Q

US US FD FDA Experience Experience in in the the Re Regulatory Applic Applicatio ion of of (Q (Q)S )SAR AR Naomi L. Kruhlak, Ph.D. Division of Applied Regulatory Science Office of Clinical Pharmacology Office of Translational Sciences FDAs

447 views • 43 slides

PROTECT : from outputs to outcom es Turning regulatory science into better pharmacovigilance

PROTECT : from outputs to outcom es Turning regulatory science into better pharmacovigilance Tenth stakeholder forum on the pharmacovigilance legislation 21 September 2016 Xavier Kurz European Medicines Agency The views expressed in this

675 views • 28 slides

Enabling and leveraging research and innovation in regulatory science EMAs core

Enabling and leveraging research and innovation in regulatory science EMAs core recommendations Human Stakeholders Workshop Presented by Alison Cave on 24 October 2018 Principal Scientific Administrator in the Surveillance & Epidemiology

109 views • 9 slides

Integrating Communication Research and Tobacco Regulatory Science Implications for Policy and

Integrating Communication Research and Tobacco Regulatory Science Implications for Policy and Practice Andy Tan Assistant Professor in Social and Behavioral Sciences Dana-Farber Cancer Institute & Harvard T.H. Chan School of Public

608 views • 59 slides

EMA Regulatory Science to 2025 Session I: Challenges and opportunities across theregulatory

EMA Regulatory Science to 2025 Session I: Challenges and opportunities across theregulatory framework View from veterinarians London, 6 December 2018 Nancy De Briyne FVE Deputy Executive Director Federation of Veterinarians of Europe

405 views • 11 slides

Regulatory Models and Layering Current Regulatory Models Telephone Cable TV Internet Cell

Scott Jordan Department of Computer Science University of California, Irvine Regulatory Models and Layering Current Regulatory Models Telephone Cable TV Internet Cell Phone Content (OSI Content (OSI Content (OSI Content (OSI layer 7)

398 views • 13 slides

Responding to the needs of the 21st century Patient: Addressing challenges and opportunities

Responding to the needs of the 21st century Patient: Addressing challenges and opportunities across the European Regulatory Framework View from the industry Alan Morrison MSD and Chair, EFPIA Regulatory Strategy Committee EMA Regulatory Science

353 views • 9 slides

Regulatory Science: Are regulators leaders or follow ers? Health data to support m edicines

Regulatory Science: Are regulators leaders or follow ers? Health data to support m edicines regulation: - identifying the opportunities - im proving the m ethods - building the capacity Presented by: Dr Peter Arlett Head, Pharm acovigilance

956 views • 60 slides

ACHIEVING STRATEGIC PRIORITIES WITH REGULATORY SCIENCE Cathy L. Backinger, PhD, MPH Deputy Director

ACHIEVING STRATEGIC PRIORITIES WITH REGULATORY SCIENCE Cathy L. Backinger, PhD, MPH Deputy Director for Research Dana M. van Bemmel, PhD, MPH Assistant Deputy Director for Research Office of Science, Center for Tobacco Products, FDA September 18,

686 views • 21 slides